Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women

Tools

Item Type:	Article
Title:	Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women
Creators:	Cust, A.E., Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Lukanova, A., Rinaldi, S., Dossus, L., Slimani, N., Lundin, E., Tjonneland, A., Olsen, A., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Joulin, V., Linseisen, J., Rohrmann, S., Pischon, T. ORCID: https://orcid.org/0000-0003-1568-767X, Boeing, H., Trichopoulos, D., Trichopoulou, A., Benetou, V., Palli, D., Berrino, F., Tumino, R., Sacerdote, C., Mattiello, A., Quiros, J.R., Mendez, M.A., Sanchez, M.J., Larranaga, N., Tormo, M.J., Ardanaz, E., Bueno-de-Mesquita, H.B., Peeters, P.H., van Gils, C.H., Khaw, K.T., Bingham, S., Allen, N., Key, T., Jenab, M. and Riboli, E.
Abstract:	Adiponectin, an adipocytokine secreted by adipose tissue, is decreased in obesity, insulin resistance, type 2 diabetes, and polycystic ovary syndrome, all of which are well-established risk factors for endometrial cancer.
Keywords:	Adiponectin, Body Mass Index, Case-Control Studies, Endometrial Neoplasms, Postmenopause, Premenopause, Prospective Studies, Risk Factors
Source:	Journal of Clinical Endocrinology and Metabolism
ISSN:	0021-972X
Publisher:	Endocrine Society
Volume:	92
Number:	1
Page Range:	255-263
Date:	January 2007
Official Publication:	https://doi.org/10.1210/jc.2006-1371
PubMed:	View item in PubMed

Repository Staff Only: item control page